Several possible studies
Story checked
NEC contributes to AI powered vaccine design through the EU funded PREPAIR VAC pandemic preparedness project (opens in a new tab)
news-medical.net · 2026-10-27
Short answer
Several possible studiesStudy not confirmed.
Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.
These papers were considered as possible sources, but none could be confirmed as the study behind this story.
Share this check
The story
NEC contributes to AI powered vaccine design through the EU funded PREPAIR VAC pandemic preparedness project
news-medical.net · 2026-10-27
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Multiple potential source studies identified.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
View article claimsSearch result
Several studies could fit.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
Evidence layer
Claim by claim
The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedNEC Corporation is participating in PREPAIR VAC, a Horizon Europe–funded research project focused on strengthening pandemic preparedness through AI in vaccine design.View evidenceHide evidence
As statedfour-year research grant; approximately €6.5 M total budget
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 2 of 5Not checkedThe grant began in September 2026 and is being carried out with several European partners in a research consortium.View evidenceHide evidence
As statedfour-year research grant beginning in September 2026
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 3 of 5Not checkedNEC OncoImmunity AS is responsible for AI-powered antigen prediction and vaccine design, with the goal of anticipating viral evolution and designing broadly protective antigens.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 4 of 5Not checkedThe consortium aims to develop broadly protective vaccine candidates and reduce the time from pathogen identification to vaccine design.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 5 of 5Not checkedThe project is intended to produce a proof-of-concept package using preclinical and translational models and also address responsible use of AI, public trust, and regulatory considerations.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Method layer
Study not confirmed.
The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.
Search results
Candidate papers, not confirmed sources.
PubMed, Crossref, Europe PMC · 15 candidate papers
Bacterial mRNA Vaccines: Programming Immunity Against Antimicrobial Resistance.
Drug Development Research · 2026 · PubMed
4956278 Anaplasma marginale antigen, antigen compositions, vaccine and process for the production of said antigen, antigen compositions and vaccine
Comparative Immunology, Microbiology and Infectious Diseases · 1991 · Crossref
Artificial intelligence for coordinating vaccine design, antiviral discovery, and real-world monitoring in the era of emerging and endemic viral threats.
2026 · Europe PMC
Artificial intelligence-driven circRNA vaccine development: multimodal collaborative optimization and a new paradigm for biomedical applications.
Briefings in Bioinformatics · 2025 · PubMed
Development of a cytotoxic T-lymphocyte-based, broadly protective influenza vaccine
Microbiology and Immunology · 2011 · Crossref